ShresthaSB, BhusalM, Jwarchan J, GautamS, Shrestha PR. Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients. J Nepal Health Res Counc [Internet]. 2023Jul.20 [cited 2024Jul.3];20(4):881-5. Available from: http://jnhrc.com.np/index.php/jnhrc/article/view/4233